Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vopr Onkol ; 38(5): 540-7, 1992.
Artigo em Russo | MEDLINE | ID: mdl-1300752

RESUMO

The effect of rigvir, an immunomodulator of the viral origin, on cell-mediated immunity was studied in patients with skin malignant melanoma. Rosette formation and monoclonal antibody techniques were used to measure blood immunocompetent cell levels in patients with the above pathology, cases of benign skin tumors and healthy subjects. Rigvir was shown to influence natural resistance by raising blood monocyte and large granule-containing lymphocyte levels. It potentiated recruitment of pre-T-lymphocytes and young active T-lymphocytes to the peripheral blood.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Enterovirus Humano B/imunologia , Melanoma/tratamento farmacológico , Neoplasias Cutâneas/tratamento farmacológico , Adulto , Idoso , Avaliação de Medicamentos , Feminino , Humanos , Imunidade Celular/efeitos dos fármacos , Masculino , Melanoma/imunologia , Pessoa de Meia-Idade , Formação de Roseta , Neoplasias Cutâneas/imunologia , Linfócitos T/imunologia , Fatores de Tempo
2.
Vopr Onkol ; 38(6): 659-66, 1992.
Artigo em Russo | MEDLINE | ID: mdl-1300766

RESUMO

Changes in E-receptor-bearing T-lymphocyte level (total and that of active T-lymphocytes) were studied in peripheral blood and resected material obtained from skin malignant melanoma and gastric cancer patients treated with rigvir, an original immunomodulator of the viral origin. Injection of rigvir into peripheral blood was followed by an increase in active T-lymphocyte level and stimulated their migration into tumor. The latter was determined by stage and rate of tumor advancement.


Assuntos
Imunoterapia Ativa , Melanoma/imunologia , Neoplasias Cutâneas/imunologia , Neoplasias Gástricas/imunologia , Linfócitos T/imunologia , Adjuvantes Imunológicos/uso terapêutico , Avaliação de Medicamentos , Enterovirus Humano B , Humanos , Contagem de Leucócitos , Melanoma/patologia , Melanoma/terapia , Estadiamento de Neoplasias , Formação de Roseta , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/terapia , Neoplasias Gástricas/patologia , Neoplasias Gástricas/terapia , Fatores de Tempo
3.
Eksp Onkol ; 11(5): 43-8, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2791955

RESUMO

It has been established that the complex systemic and local administration of human ECHO-7 virus exerts an inhibitory effect on the growth of MX-17 tumour in the BALB/c mice without the signs of viral oncolysis. The antitumour effect is due to a modulation of the antitumour immunity (immunological regression) against a background of the viral immunogenesis.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Enterovirus Humano B/imunologia , Rabdomiossarcoma/terapia , Animais , Linfonodos/imunologia , Linfócitos/imunologia , Masculino , Metilcolantreno/toxicidade , Camundongos , Camundongos Endogâmicos BALB C , Rabdomiossarcoma/induzido quimicamente , Timo/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...